Literature DB >> 2320711

DSP-4-induced depletion of brain norepinephrine produces opposite effects on exploratory behavior 3 and 14 days after treatment.

C W Berridge1, A J Dunn.   

Abstract

Exploratory behavior of a complex novel environment was examined 3 and 14 days following treatment with the noradrenergic-selective neurotoxin, DSP-4. This toxin significantly decreased norepinephrine concentrations in neocortex and hippocampus but not hypothalamus. DSP-4 significantly increased exploratory behavior in animals tested 3 days after treatment. In contrast, exploratory behavior was decreased in animals tested 14 days after treatment. The effect of DSP-4 at 3 days is similar to treatments that act to inhibit noradrenergic function such as administration of the alpha 1-antagonist, prazosin, or the alpha 2-agonist, clonidine. The effect of DSP-4 at 14 days resembles that observed following treatment with the alpha 1-agonist, phenylephrine, or the alpha 2-antagonist, idazoxan. These data provide additional support for a role of noradrenergic systems in exploratory behavior. The simplest explanation for the time dependent effects of DSP-4 on exploratory behavior is the occurrence of the slow development of a supersensitivity of cerebral systems affected by norepinephrine.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2320711     DOI: 10.1007/bf02244003

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  18 in total

1.  Altered responsiveness of adenosine 3',5'-monophosphate-generating systems in rat cortical slices after lesions of the medial forebran bundle.

Authors:  R K Dismukes; P Ghosh; C R Creveling; J W Daly
Journal:  Exp Neurol       Date:  1975-12       Impact factor: 5.330

2.  Identity of [3H]-dihydroalprenolol binding sites and beta-adrenergic receptors coupled with adenylate cyclase in the central nervous system: pharmacological properties, distribution and adaptive responsiveness.

Authors:  A Dolphin; J Adrien; M Hamon; J Bockaert
Journal:  Mol Pharmacol       Date:  1979-01       Impact factor: 4.436

3.  Binding of alpha-and beta-adrenergic ligands to cerebral cortical membranes: effect of 6-hydroxydopamine treatment and relationship to the responsiveness of cyclic amp-generating systems in two rat strains.

Authors:  P Skolnick; L P Stalvey; J W Daly; E Hoyler; J N Davis
Journal:  Eur J Pharmacol       Date:  1978-01-15       Impact factor: 4.432

4.  Restraint-stress-induced changes in exploratory behavior appear to be mediated by norepinephrine-stimulated release of CRF.

Authors:  C W Berridge; A J Dunn
Journal:  J Neurosci       Date:  1989-10       Impact factor: 6.167

5.  Locus ceruleus lesion by local 6-hydroxydopamine infusion causes marked and specific destruction of noradrenergic neurons, long-term depletion of norepinephrine and the enzymes that synthesize it, and enhanced dopaminergic mechanisms in the ipsilateral cerebral cortex.

Authors:  S I Harik
Journal:  J Neurosci       Date:  1984-03       Impact factor: 6.167

6.  Supersensitivity of alpha 2-adrenoceptors modulating [3H]5-HT release after noradrenergic denervation with DSP4.

Authors:  S Benkirane; S Arbilla; S Z Langer
Journal:  Eur J Pharmacol       Date:  1985-12-10       Impact factor: 4.432

7.  Stress produces opioid-like effects on investigatory behavior.

Authors:  A F Arnsten; C Berridge; D S Segal
Journal:  Pharmacol Biochem Behav       Date:  1985-05       Impact factor: 3.533

8.  Stages of recovery from central norepinephrine lesions in enriched and impoverished environments: a behavioral and biochemical study.

Authors:  J Diaz; G Ellison; D Masouka
Journal:  Exp Brain Res       Date:  1978-01-18       Impact factor: 1.972

9.  Functional supersensitivity to adrenergic agonists in the rat after DSP-4, a selective noradrenergic neurotoxin.

Authors:  D J Dooley; E Mogilnicka; A Delini-Stula; F Waechter; A Truog; J Wood
Journal:  Psychopharmacology (Berl)       Date:  1983       Impact factor: 4.530

10.  Pharmacological modifications of the neurotoxic action of the noradrenaline neurotoxin DSP4 on central noradrenaline neurons.

Authors:  H Hallman; G Jonsson
Journal:  Eur J Pharmacol       Date:  1984-08-17       Impact factor: 4.432

View more
  12 in total

1.  Influence of noradrenaline denervation on MPTP-induced deficits in mice.

Authors:  T Archer; A Fredriksson
Journal:  J Neural Transm (Vienna)       Date:  2005-12-16       Impact factor: 3.575

2.  Effects of locus coeruleus activation on electroencephalographic activity in neocortex and hippocampus.

Authors:  C W Berridge; S L Foote
Journal:  J Neurosci       Date:  1991-10       Impact factor: 6.167

3.  Functional consequences of iron overload in catecholaminergic interactions: the Youdim factor.

Authors:  Trevor Archer; Anders Fredriksson
Journal:  Neurochem Res       Date:  2007-08-12       Impact factor: 3.996

Review 4.  Noradrenergic modulation of wakefulness/arousal.

Authors:  Craig W Berridge; Brooke E Schmeichel; Rodrigo A España
Journal:  Sleep Med Rev       Date:  2012-01-31       Impact factor: 11.609

5.  Effects of clonidine and alpha-adrenoceptor antagonists on motor activity in DSP4-treated mice I: dose-, time- and parameter-dependency.

Authors:  T Archer; A Fredriksson
Journal:  Neurotox Res       Date:  2000-04       Impact factor: 3.911

6.  Enhancement of behavioral and electroencephalographic indices of waking following stimulation of noradrenergic beta-receptors within the medial septal region of the basal forebrain.

Authors:  C W Berridge; S L Foote
Journal:  J Neurosci       Date:  1996-11-01       Impact factor: 6.167

7.  The effect of the alpha2-adrenoreceptor antagonist idazoxan against 6-hydroxydopamine-induced Parkinsonism in rats: multiple facets of action?

Authors:  J Srinivasan; Werner J Schmidt
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2004-04-29       Impact factor: 3.000

8.  Effects of alpha-adrenoceptor agonists in chronic morphine administered DSP4-treated rats: evidence for functional cross-sensitization.

Authors:  T Archer; A Fredriksson
Journal:  Neurotox Res       Date:  2001-10       Impact factor: 3.911

Review 9.  Noradrenergic modulation of arousal.

Authors:  Craig W Berridge
Journal:  Brain Res Rev       Date:  2007-12-04

Review 10.  Targeting modulation of noradrenalin release in the brain for amelioration of REMS loss-associated effects.

Authors:  Abhishek Singh; Birendra Nath Mallick
Journal:  J Transl Int Med       Date:  2015-03-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.